Novavax Files Annual Report to Security Holders
Ticker: NVAX · Form: ARS · Filed: Apr 27, 2026 · CIK: 0001000694
| Field | Detail |
|---|---|
| Company | Novavax Inc (NVAX) |
| Form Type | ARS |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, shareholder-reporting
Related Tickers: NVX
TL;DR
NVX filed its 2025 ARS. Check financials.
AI Summary
Novavax Inc. filed an Annual Report to Security Holders (ARS) on April 27, 2026, for the period ending December 31, 2025. The filing includes documents related to the company's operations and financial reporting. Novavax Inc. is headquartered in Gaithersburg, MD.
Why It Matters
This filing provides shareholders with an overview of Novavax's performance and financial standing for the fiscal year 2025, which is crucial for investment decisions.
Risk Assessment
Risk Level: medium — Annual reports can contain significant financial and operational details that may impact a company's stock price.
Key Numbers
- 17571962 — ARS Document Size (Size of the primary ARS PDF document.)
- 24202882 — Submission Text File Size (Size of the complete submission text file.)
Key Players & Entities
- Novavax Inc. (company) — Filer
- 21 FIRSTFIELD RD GAITHERSBURG MD (location) — Mailing and Business Address
- 2025-12-31 (date) — Period of Report
- 2026-04-27 (date) — Filing Date
FAQ
What is the CIK number for Novavax Inc.?
The CIK number for Novavax Inc. is 0001000694.
What is the fiscal year end for Novavax Inc.?
The fiscal year end for Novavax Inc. is December 31 (1231).
What is the SIC code for Novavax Inc.?
The SIC code for Novavax Inc. is 2836, which pertains to Biological Products, (No Diagnostic Substances).
What is the state of incorporation for Novavax Inc.?
Novavax Inc. is incorporated in Delaware (DE).
What is the filing type for accession number 0001104659-26-049137?
The filing type is ARS (Annual Report to Security Holders).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 27, 2026 regarding NOVAVAX INC (NVAX).